we love the company

henshengqi
2021-10-27

$BioNTech SE(BNTX)$ We know we'll be establishing decent Revenue in Q3...maybe the IB analysts median to high-end range is realistic. Then we have to concern ourselves with the "what about Q4 and beyond to 22/23" stuff. Some are jittery here with the unknown in that timeframe as well they should be. Lots of variables at play with Covid, variants, vax deniers, politics,, mandates, competition, etc. The future is a moving target to say the least. Looooong term we can all say we love the company and it's mRNA outlook against various diseases.

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法